Companies: 10,795·Total market cap: $144.5T
Restart Life Sciences Corp.

Restart Life Sciences Corp.

NMLSFOTCHealthcare● Active
$0.04
+$0.00(+0.00%)
Market Cap$1279264
P/E Ratio—
52W High$0.12422
52W Low$0.0101
Overview

Restart Life Sciences Corp. (NMLSF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

NMLSF · shares outstanding · updated Jun 15, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
3.390B▼ -77.82% YoY Change
FY · as of Dec 31, 2025 · Reported in CAD
vs 15.286B in FY 2024
Diluted Shares Outstanding
3.390B
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
-77.82%
year-over-year
Float (Free Float)
28.3M
publicly tradable shares
77.3% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-15

Shares Outstanding Growth Rate

3-Year CAGRdeclining
-37.1%
2022 → 2025
5-Year CAGRdeclining
-7.9%
2020 → 2025
10-Year CAGRincreasing
+14.3%
2015 → 2025
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 3.390B
3.390B
-77.82%
FY 2024
Diluted Shares: 15.286B
15.286B
+3.87%
FY 2023
Diluted Shares: 14.717B
14.717B
+7.76%
FY 2022
Diluted Shares: 13.656B
13.656B
+22.92%
FY 2021
Diluted Shares: 11.110B
11.110B
+117.20%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs NMLSF
#1
Restart Life Sciences Corp.NMLSF
Restart Life Sciences Corp.YOU
3.390B—
#2
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B-26.2%
#3
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B-28.4%
#4
Novartis AGNVS
Novartis AG
1.939B-42.8%
#5
AbbVie Inc.ABBV
AbbVie Inc.
1.780B-47.5%
#6
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M-73.2%
#7
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M-73.5%

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Restart Life Sciences Corp. (NMLSF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, Restart Life Sciences Corp. reports 3.390B basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Restart Life Sciences Corp.'s basic shares outstanding (3.390B) represents currently issued shares. Diluted shares outstanding (3.390B) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Restart Life Sciences Corp.'s float is 28.3M (77.3% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float28.3M(77.3%)
Outstanding36.6M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · CAD

About shares outstanding & methodology

Restart Life Sciences Corp. (NMLSF) shares outstanding history from 2006 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Restart Life Sciences Corp. shares outstanding for the fiscal year ending December 31, 2025 were 3.390B, a 77.82% decline year-over-year. Restart Life Sciences Corp. FY 2025 shares outstanding were 3.390B, a -77.82% decline from FY 2024.

Restart Life Sciences Corp. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +14.3% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

NMLSF shares outstanding · 4 questions

As of December 31, 2025, Restart Life Sciences Corp. (NMLSF) has approximately 3.390B basic shares outstanding and 3.390B diluted shares outstanding. This represents a -77.82% year-over-year change from FY 2024 (15.286B). Restart Life Sciences Corp.'s declining share count is primarily driven by its share buyback program. For the complete historical data table, see the history table above.

NMLSF shares outstandinghow many shares does NMLSF haveNMLSF basic shares 2025NMLSF diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Restart Life Sciences Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-15